Society of Maternal–Fetal Medicine Annual Meeting and a Continuing Medical Education Course: Results of Pre- and Postcourse Survey

Abstract

Objective To assess the influence of a continuing medical education (CME) course on knowledge acquired and potential to change clinical management or opinion.

Study Design During the annual Society of Maternal–Fetal Medicine meeting, a survey consisting of 11 knowledge-based, 10 management plan, and 8 opinion questions was administered at the start and completion of the CME course. Chi-square and Fisher exact test were used, and p < 0.05 was considered significant.

Results The survey was administered electronically to 394 attendees. Questions assessing knowledge showed significant improvement with 91% (10/11) of queries. Purported management changed significantly with 60% (6/10) scenarios and opinions in 62% (5/8) of clinical situations.

Conclusion A survey done at the completion of a course indicates that CME improves knowledge and can change management and opinions. The prolonged benefits of CME need to be investigated.

Keywords

CME - pre-course - postcourse - MFM - survey

• References

• 1 Moores LK, Dellert E, Baumann MH, Rosen MJ ; American College of Chest Physicians Health and Science Policy Committee. Effectiveness of continuing medical education: American College of Chest Physicians evidenced based educational guidelines. Chest 2009; 135 (3, Suppl) 5S-7S
• 2 Practice bulletin no. 113: inherited thrombophilias in pregnancy. Obstet Gynecol 2010; 116: 212-222
• 3 Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH. ; Fetal Medicine Foundation Second Trimester Screening Group. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007; 357: 462-469
• 4 Berghella V, Odibo AO, To MS, Rust OA, Althuisius SM. Cerclage for short cervix on ultrasonography: meta-analysis of trials using individual patient-level data. Obstet Gynecol 2005; 106: 181-189
• 5 Society for Maternal Fetal Medicine Publications Committee. ACOG Committee Opinion number 419 October 2008 (replaces no. 291, November 2003). Use of progesterone to reduce preterm birth. Obstet Gynecol 2008; 112: 963-965
• 6 Crowther CA, Hiller JE, Doyle LW, Haslam RR ; Australasian Collaborative Trial of Magnesium Sulphate (ACTOMg SO4) Collaborative Group. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA 2003; 290: 2669-2676
• 7 Rouse DJ, Hirtz DG, Thom E , et al; Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units Network. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med 2008; 359: 895-905
• 8 Norwitz ER, Bahtiyar MO, Sibai BM. Defining standards of care in maternal-fetal medicine. Am J Obstet Gynecol 2004; 191: 1491-1496
• 9 American College of Obstetricians and Gynecologists Committee on Obstetric Practice; Society for Maternal-Fetal Medicine. Committee Opinion No. 455: Magnesium sulfate before anticipated preterm birth for neuroprotection. Obstet Gynecol 2010; 115: 670
• 10 Al-Niaimi A, Chauhan SP, Gupta LM, Bailet JW. Factors influencing the evolving practice of obstetricians in eastern Wisconsin: a survey. Am J Perinatol 2008; 25: 321-324